NR Supplement FDA References: Read the Actual Scope of a GRAS Response Letter
Distinguish a retail capsule label, manufacturer notification claims and an FDA letter about specified conventional-food uses.
We have not performed hands-on testing of the products discussed. Manufacturer references and official guidance support the documented information below; comparison exercises are our editorial guidance.
A supplement website may mention several FDA-related processes near one product. Combining them into a single approved badge loses the scope of each document. The nicotinamide-riboside example below traces a manufacturer claim to an actual FDA response letter. This guide interprets the evidence trail; it does not recommend NR, confirm a claimed effect or establish personal suitability.
Identify the retail product separately from the ingredient record
Tru Niagen’s consulted 300 mg capsule panel identifies NIAGEN as nicotinamide riboside chloride. Its quality page discusses New Dietary Ingredient notifications and a GRAS notification. Keep the capsule label, those attributed maker statements and the regulator documents in distinct fields. A reference to the branded ingredient is not automatically a response letter covering every finished product or every advertised purpose in the brand’s range.
Read the intended uses in the FDA letter
FDA’s response to GRAS Notice 635 concerns nicotinamide riboside chloride in specified conventional-food categories. The letter states that FDA had no questions at that time regarding the notifier’s conclusion under the intended conditions and had not made its own GRAS determination. It also says the office did not evaluate support for labelling claims. Those limitations belong with the document, rather than being replaced by a blanket approval description.
Worked example: replace an overbroad regulatory badge
Imagine an illustrative comparison card labels a retail capsule FDA approved for its advertised results because the manufacturer links to a GRAS notification. Replace that badge with the exact notice number, ingredient name, intended-use scope and response date. Keep the retail capsule’s panel on its own row. Any claim about the capsule’s effects remains outside what this particular letter establishes. No personal intake threshold should be calculated from the food-use conditions in the notice.
Keep notification pathways and markets distinct
FDA’s NDI background material describes a separate supplement-ingredient notification process. A shopping record should therefore identify which pathway a seller is citing rather than treating GRAS and NDI as synonyms. Request the actual referenced document if the page gives only a logo or shorthand. Do not extend a US food-use letter into permission to market a product in another country. This analysis does not adjudicate the manufacturer’s legal compliance or evaluate the clinical literature; it clarifies what the consulted letter can support. A buyer can retain useful regulatory documentation while still leaving product-effect, exact-offer and local-classification questions unresolved. That narrower record is more reviewable than an affirmative badge with no defined scope.
Compare the trade-offs
| Option | Useful when | Purchase limitation |
|---|---|---|
| Retail capsule | Its own complete ingredient panel | A finished-product record is distinct from a food-use notice |
| GRAS response 635 | Intended conditions and explicit limitations | No blanket product or claim approval inferred |
| NDI reference | Identify the separate notification document | Different pathways should not share one approval badge |
Your purchase checklist
- Save the actual regulator document and date.
- Retain the intended-use and claim-evaluation limitations.
- Do not convert food-use conditions into a personal intake rule.
Sources and further reading
- Tru Niagen: 300 mg retail capsule panel
- Tru Niagen: manufacturer quality-page notification statements
- FDA: agency response letter GRAS Notice 635
- FDA: NDI notification background and scope
Reference links concern the stated topic or example. They do not indicate endorsement of this publication. Product versions, local labels, availability and seller terms can change; verify the exact listing before ordering.